Just how much is Indiana University driving Indiana’s culture of innovation and entrepreneurship? Look no further than the list of nominees for the 2025 Mira Awards, honoring the best of tech in Indiana. TechPoint, Central Indiana Corporate Partnership’s industry-led growth initiative for Indiana’s digital innovation economy, recently announced more than a dozen IU-affiliated tech leaders… Read more »
Tag: Uncategorized
IU celebrates opening of The Forge, Bloomington’s new tech center
Indiana University helped lead an all-out celebration “blitz” on Friday, Nov. 22, at the grand opening of The Forge, Bloomington’s new $13 million sustainable technology center in the city’s downtown Trades District. Even though IU’s football team suffered its first defeat the following day, Bloomington is still buzzing with excitement over two of its biggest… Read more »
IU microelectronics innovation to help fuel formation of new $285M national semiconductor institute
Indiana University will play a key role in the formation of a first-of-its-kind national institute targeting the next frontier of technological innovation in the microelectronics industry. IU is a member of the team that was selected this week by the National Institute for Standards and Technology to launch the new Semiconductor Manufacturing and Advanced Research… Read more »
IU researcher attends White House event on saving lives from opioid overdose
After participating in a special event at the White House this week, Indiana University researcher Cris Henderson is confident that IU’s leadership in helping to prevent opioid overdoses is moving Indiana and the nation in the right direction. Henderson is a research associate for Prevention Insights and a doctoral student at the IU School of… Read more »
IU faculty startup MBX Biosciences announces $163.2 million U.S. IPO
MBX Biosciences, an Indiana University faculty-created startup that develops peptide therapies for the treatment of endocrine and metabolic diseases, raised $163.2 million in its U.S. initial public offering. The company’s peptides are based on chemistry developed by a research team led by Richard DiMarchi, scientific cofounder of MBX Biosciences and Distinguished Professor of Chemistry in… Read more »
IU researcher develops anticounterfeit tags and environmental sensors using nanoparticles
From apparel to pharmaceuticals, the global impact of counterfeit goods can reach up to $1.7 trillion annually across numerous markets. To tackle this important issue, Indiana University research chemist Sara Skrabalak is using nanoparticles to develop anticounterfeit tags and environmental sensors that mark critical components to confirm if an item has been tampered with. She… Read more »
IU researcher engineers data-processing architectures in fibers
To meet the demands of the Internet of Tomorrow, Indiana University researcher and entrepreneur Alexander Gumennik is advancing smart fibers that could lead to improvements in the management of biomedical and biohazardous materials, the monitoring of our environment and the human body, optical treatments and more. Gumennik is interested in collaborating with industry partners to… Read more »
Patents awarded to six IU innovations
Six Indiana University-led technologies and methods have recently received patents from the U.S. Patent and Trademark Office. These innovations include an antiviral drug treatment for HPV, as well as methods for activating T cells in vitro, processing speech, enhancing the study of the gut microbial ecosystem, analyzing lipoproteins through the use of mass spectrometry and… Read more »
IU researcher pioneers new class of antibiotics to treat infectious diseases
An Indiana University researcher is pioneering an innovative approach to develop new antibiotics that could help address the growing problem of bacterial antimicrobial resistance, which is when bacteria and viruses no longer respond to antibiotic medicines. Recent estimates indicate that each year there are 5 million infections globally associated with bacterial antimicrobial resistance, with 1.3… Read more »
IU researcher uses revolutionary method to develop anticancer therapeutics
When developing anticancer therapeutics, most researchers aim to kill cancerous cells. However, Hiroki Yokota’s approach is to control their growth by knowing how to grow them. Yokota, a professor of biomedical engineering at the School of Engineering and Technology at IUPUI, an adjunct professor of anatomy, cell biology and physiology at the IU School of… Read more »